Case report demonstrates pharmacogenomic testing reduces trial-and-error prescribing in mental health disorders, indicating improved therapy tolerance through precision care.
Key Clinical Message Pharmacogenomic testing is a valuable precision health tool for managing depression and other mental health conditions, from treatment‐naïve patients to those with multiple medication failures. It can reduce trial‐and‐error prescribing, guide dosing, and improve therapy tolerance, supporting more individualized and effective care.
No takes yet. Share an insight, caveat, or question.
Swanson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: